SC 13D

Company

Lyra Therapeutics, Inc.

Filed

May 15, 2020

Accession Number

0001193125-20-144122

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →